Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank40
3Y CAGR-78.2%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
-78.2%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$838.00-50.4%
2024$1688.00+3.9%
2023$1625.00-98.0%
2022$80648.00+134.3%
2021$-235136.00-
2020$0.00-